In contrast to pancreatic cancer, where CUX1 is oncogenic, highly expressed and suppresses TRAIL-induced apoptosis through unclear mechanisms54, we propose that CUX1 haploinsufficiency in myeloid malignancies confers a reliance on CFLAR-regulated anti-apoptotic survival. This evidence concerns the gene CUX1 and pancreatic neoplasm.